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Key Messages
Why this paper is important
 The essential amino acid L-lysine was demonstrated to have a selective impact on food intake, gastric
emptying, and intestinal transit in rats, thus indicating a potential novel direct sensory input to assess dietary
protein content and quality. This work represents an important translational extension of reported findings
using magnetic resonance imaging (MRI) in human subjects and standard lethal measurements in rats. We
show that intragastric L-lysine exhibits a comparable dose-dependent effect on GI motility and secretion in
humans and rats. We strongly believe that these translational findings further support the broad role of specific
amino acids in the control of GI function in vivo.
The aim of the research work
 The aim of this study was to assess the translational aspects of recent findings in rats demonstrating a selective
impact of L-Lysine on gastrointestinal (GI) function and to investigate the dose-dependent effect of L-lysine on
human and rat GI function.
Basic methodology of study
 L-lysine doses from 0–800 mg in rats and 0.5–7.5 g in humans were analyzed for their effect on gastric emptying
and GI secretion. Human GI function was assessed non-invasively using MRI, rat data were acquired using
standard lethal measurement methods.
Summarizing key results
 A dose-dependent delay in gastric emptying was observed in humans with an increase in halftime of gastric
emptying of 4 min/g L-lysine, p < 0.01. A dose-dependent increase in intestinal fluid accumulation was
observed (0.4 mL/min/g L-lysine, p < 0.0001).
Abstract
Background Novel sensory inputs for the control of
food intake and gastrointestinal (GI) function are of
increasing interest due to the rapid increase in
nutrition-related diseases. The essential amino acid
L-lysine was demonstrated to have a selective impact
on food intake, gastric emptying, and intestinal
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transit in rats, thus indicating a potential novel
direct sensory input to assess dietary protein content
and quality. The aim of this study was to assess
translational aspects of this finding and to investigate
the dose-dependent effect of L-lysine on human and
rat GI function. Methods L-lysine doses from 0–
800 mg in rats and 0.5–7.5 g in humans were ana-
lyzed for their effect on gastric emptying and GI
secretion. Human GI function was assessed non-
invasively using magnetic resonance imaging (MRI),
rat data were acquired using standard lethal mea-
surement methods. L-lysine dose dependently
delayed gastric emptying and stimulated GI secretion
in rats as reflected by residual phenol red content
and increased gastric wet weight. Key Results The
dose-dependent delay in gastric emptying observed in
rats was confirmed in humans with an increase in
halftime of gastric emptying of 4 min/g L-lysine,
p < 0.01. Moreover, a dose-dependent increase in
intestinal fluid accumulation was observed (0.4 mL/
min/g L-lysine, p < 0.0001). No effect on alkaline
tide, glucose concentration, hematocrit, or visceral
sensations was detected. Conclusions & Inferences
This translational study demonstrates comparable
dose-dependent effects of intragastric L-lysine on GI
function in humans and rats and suggests a broader
role for individual amino acids in the control of GI
motility and secretion in vivo.
Keywords gastric emptying, gastrointestinal function,
L-lysine, MRI.
INTRODUCTION
The worldwide rapid increase in nutrition and in
particular obesity-related diseases stimulated efforts
to understand how a meal impacts on various
physiological processes including gastrointestinal
(GI) function. Upon food intake, GI function adapts
quickly to the ingested meal presumably to control
efficient digestion and absorption of the vital nutri-
ents. This dynamic plasticity is regulated by mech-
anisms responding to properties specific to the
ingested meal such as their caloric content, volume,
and consistency. This multiple signaling input is
integrated to some extent by the autonomous ner-
vous and endocrine systems to control proper GI
function.1
The macronutrient composition of a meal is com-
monly not considered to have a major impact on GI
function.2,3 This is in contrast to newly emerging
concepts demonstrating macronutrient-specific con-
trol of different vagal and endocrine signals. For
instance, specific individual amino acids induce vagal
afferent firing or stimulate the release of different GI
hormones ex vivo.4–8 The in vivo relevance of these
findings in the context of GI function control has
typically been extrapolated from studies showing that
high protein diets delayed gastric emptying to a larger
extent than isocaloric control diets in both humans
and rats.9,10 Controversially, others could not confirm
these observations.11 As high protein diets are com-
posed of different individual amino acids and thereby
considerably vary between laboratories, this might
obscure amino acid-specific effects. So far, no study
systematically tested the impact of all the 20 indi-
vidual amino acids on GI function in humans or rats.
Therefore, the selection of candidate amino acids was
based on a recent study in rats revealing that
L-arginine, L-lysine, and L-glutamic acid induced the
most potent anorectic effect compared to isomolar
doses of all other proteogenic amino acids.12 Within
this study, L-lysine was shown to delay solid gastric
emptying, induce gastric secretion, and increase
intestinal motility, thereby revealing an amino acid-
specific impact on GI function in vivo. Several
aspects remained elusive. Neither the dose-dependent
effect nor the temporal dynamics of L-lysine were
resolved, but both are relevant for the characteriza-
tion of the pharmacokinetic effect of L-lysine. Most
importantly, it remained unclear if humans show a
similar GI response to a gastric load of L-lysine.
Humans and rodents significantly differ in GI anat-
omy and physiology even though from an ingestive
perspective both are omnivores. For instance, rats eat
10–20% of their bodyweight equivalent as food every
day, whereas healthy humans at best 2%. Moreover,
rats do not have a gallbladder and lack the vomiting
reflex.
The aim of this study was to identify the dose-
dependent effect of L-lysine on human and rat GI
function after intragastric infusion or gavage, respec-
tively. Animal experiments were restricted to the
30 min time point due to lethal methods. GI function
was analyzed by measurements of wet weight and
residual phenol red content. In humans, magnetic
resonance imaging (MRI) and venous blood sampling
were applied to repeatedly assess gastric meal, secre-
tion, and intestinal fluid content volume as well as
blood parameters every 15 min for over 90 min.
Human experiments were performed in healthy vol-
unteers within a randomized, double-blind, three-
armed, cross-over study design. The study revealed a
conserved impact of L-lysine on GI function in
humans and rats.
© 2014 John Wiley & Sons Ltd1000
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MATERIALS AND METHODS
Ethical approval
All procedures for rat handling and experimental interventions
were according to the Swiss Animal Welfare laws and approved by
the Kantonales Veterin€aramt Z€urich. The human study was
performed between April and September 2012 in a single center,
randomized, double-blind, 3-armed, unbalanced, cross-over study
design and in accordance with the Declaration of Helsinki, Good
Clinical Practice. It was registered at ClinicalTrial.gov with
identifier NCT01212614. The local Ethics Committee approved
the study and all volunteers gave written informed consent.
Animal care
Thirty male Wistar rats (Janvier, Saint Berthevin Cedex, France)
were grouped housed (room temperature 21  1 °C, artificial 12/
12 h light–dark cycle) with water and food (3433 Kliba Nafag,
Kaiseraugst, Switzerland) available ad libitum unless noted
otherwise.
Animal dose preparation
L-lysine of 0, 25, 50, 100, 200, and 400 mg/mL (Sigma-Aldrich,
Buchs, Switzerland) was solubilized in tap water and 80, 75, 70,
60, and 40 mg/mL NaCl (Sigma-Aldrich) proportionally added to
correct for molarity differences. pH was adjusted to 7.2 using HCl
(Merck, Zug, Switzerland). The applied volume was 2 mL for each
of these solutions supplemented with 1.5 mg phenol red (Sigma-
Aldrich).
Animal experimental design
Animals were food deprived for 4 h prior oral L-lysine admin-
istration to ensure similar residual stomach content. Rats
received intragastric application of 2 mL of the respective
L-lysine dose and were returned to their home cage, where they
did not have access to food or water. Thirty minutes postappli-
cation, animals were euthanized using pentobarbital (IP,
100 mg/kg, Kantonsapotheke Z€urich, Switzerland) in combina-
tion with isoflurane (5%) for quicker induction. The GI tract
was excised and segmented into stomach, small intestine,
cecum, and colon based on anatomical landmarks using clamps
to limit liquid loss. The wet weight of each segment was
immediately measured. Phenol red was extracted from each
segment and quantified by optical spectroscopy at 560 nm
wavelength as described previously.12
Animal Statistics
Rats were randomly allocated into the six treatment groups.
Application order was randomized and statistical analysis per-
formed as described for the human data set below.
Human Subjects
Six healthy subjects aged between 18 and 50 years (four male, two
female, BMI 22  1 kg/m2) were recruited via a public advertise-
ment. A T-test-based power analysis was performed based on data
from a previous study in 14 healthy subjects that measured the
production rate of gastric secretion after intake of a secretion
stimulating test meal.13 A statistical power of 0.83 was deter-
mined for the inclusion of six subjects, an effect size of 1.5 and a
significance level of 0.05. Prior study inclusion, all subjects
underwent a clinical assessment and were tested negative for
helicobacter pylori. The following exclusion criteria were applied:
BMI (kg/m2) <19 or >24, history of systemic and psychiatric
disease especially GI disease or surgery (excludes appendectomy,
hernia repair, and anorectal disorders), lysineuria, galactosaemia,
medication intake of any kind, drug or alcohol abuse, presence of
metallic implants, devices or metallic foreign bodies, claustro-
phobia, pregnancy and lactation, known allergy or intolerance
against locus bean gum, L-lysine, Gadolinium (DOTAREM),
Methylparaben (E218), Fructose, Gluten, Galactose, and also
allergic reaction after prior injection of Lidocain (e.g., at the
dentist).
Human test meal
L-lysine was administered as L-lysine monohydrate (LMH, Fagron
GmbH & Co.KG, Barsbuettel, Germany) at doses of 0.5, 1.2, 3.0,
and 7.5 g in four different 300 mL test meals. The maximum
L-lysine dose of 7.5 g was selected based on literature data. Doses
up to 9 g are considered a physiological daily dose,14 however,
doses >8 g have been reported to induce diarrhea and cramps.15
Lower doses were derived using a reduction factor of 2.5. The
ingredients and properties of the four LMH test meals had
negligible caloric content (<25 kcal) and are listed in Table 1.
NaCl was proportionally added to each test meal to correct for
molarity differences. All meals were prepared directly before each
study session, heated to 37 °C, and infused within 1–2 min while
volunteers were lying in the MRI scanner.
Human measurement protocol
The human dose–response study was performed using a ran-
domized, double-blind, 3-armed, unbalanced, cross-over study
design. Three of the four L-lysine test meals were randomly
assigned to the six subjects. This unbalanced study design was
selected to receive maximum output while minimizing expo-
sure. All six subjects underwent three study sessions of 2.5 h
including subject preparation and repeated MRI and venous
blood measurements. Sessions were performed on three different
days separated by 5–21 days. Each session followed the same
procedure depicted in Fig. 1. Subjects arrived at the MR center
in the morning or at noon after fasting overnight (or for at
least 8 h). A nasogastric tube (Freka Tube CH/FR 12) was
Table 1 Ingredients and properties of the four L-lysine test meals for
human application.
Ingredients/properties
(units) Values
LMH (g) 0.5 1.2 3.0 7.5
NaCl (g) 1.24 1.12 0.8 0.0
Evian (still water; mL) 300
Locus beam gum (E410; g) 3
MR contrast agent
(Dotarem; lL)
350 (≙175 lmol ≙583.3 lM)
Osmolarity (mOsm/L) 152.52
pH 9.2 9.6 9.6 9.85
Caloric load (kcal) 2.3 4.5 10.4 25.1
© 2014 John Wiley & Sons Ltd 1001
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placed 50–60 cm from the nares after previous local anesthesia
of the nasal cavity with Lidocain-HCl 2% (prepared in house)
and Vibrocil (Novartis, Basel, Switzerland) nose gel. A venous
vascular cannula (VasofixBraun€ule) was placed on the right or
left cubital vein for subsequent blood sampling and continuous
0.9% NaCl infusion. MR image data were acquired with
subjects positioned in right decubitus before and directly after
test meal infusion and then every 15 min until 90 min. Visceral
sensations scores were recorded after each MRI scan and in
addition at 105 min after meal infusion. Blood samples were
collected before (baseline) and at 10, 25, 40, 55, 70, 85, and 100
after meal infusion. The first blood sample in fasted state and
last blood samples at 100 min were taken in sitting position, all
other samples were obtained while the subject was lying on the
MR patient table. The nasogastric tube was removed at ~60 min
with subjects in sitting position.
Human MRI and visceral sensations scores
Subjects were positioned in right decubitus inside the clinical MRI
scanner (1.5 T Achieva, Philips Healthcare, Best, The Netherland).
An abdominal phased-array surface coil (SENSE body coil, four
elements) was used for image acquisition. MR imaging consisted
of three imaging sequences to visualize gastric content volume,
gastric secretion, gallbladder volume, and intestinal fluid content.
The MRI scan parameters for gastric content volume measure-
ment were as follows: balanced steady-state free precession
sequence, 26–34 transverse slices, 6 mm slice thickness, no slice
gap, 360 mm field of view, 1.6/3.3 ms echo/repetition time, one
breath hold, 16–24 s scan duration (depending on slice number).
For assessing gastric secretion, MRI scan parameters were as
follows: radial T1-weighted gradient echo sequence with profiles
acquired in golden angle view order, 18 coronal slices, 6 mm slice
thickness, 0.6 mm slice gap, 360 mm field of view, 1.8/12 ms
echo/repetition time, free breathing, 2:24 min scan duration. To
visualize gallbladder volume and intestinal fluid content, MRI
scan parameters were as follows: T2-weighted turbo spin echo
sequence with fat suppressions, 26 coronal slices, 5 mm slice
thickness, 1 mm slice gap, 375 mm field of view, 80/1200 ms
echo/repetition time, two breath holds, 31 s scan duration.
After MRI scans, subjects had to report their visceral sensa-
tions, i.e. hunger, fullness, nausea, bloating, abdominal cramps,
and urge to defecate using a self-assessed sensations scale ranging
from 0 to 10 (0 – no sensations, 10 – extremely prominent
sensations).
Human blood sampling and analysis
For blood gas measurements assessing the alkaline tide (pH,
bicarbonate, pCO2, chloride), glucose and hematocrit, venous
blood was first collected with a serum vacutainer, then filled
within 1–3 min in heparinized capillaries, and analyzed using
the ABL 700 blood gas analyzer (Radiometer GmbH, Thalwil).
For measurements of albumin and L-lysine blood concentration,
Li-heparin vacutainers and EDTA-vacutainers were used, respec-
tively. Albumin was measured to assess a potential shift in fluid
from intravasal to intragastrointestinal. Blood samples were
directly centrifuged and ~1 mL of plasma was pipetted for
storage at 20 °C for L-lysine and 8 °C for albumin. A volume
of 50 lL of each L-lysine plasma sample was mixed with 50 lL of
10% SSA/NVal solution and centrifuged at 22639.5 g for 5 min.
A volume of 60 lL borate/NaOH buffer and 20 lL reagent
(2AMT) was added to 20 lL of the resulting supernatant and 1/
100 lL of this mixture was injected on a HPLC column using the
cell culture gradient, according to the manufacture’s protocol.
The plasma for the albumin measurement was processed with a
Cobas 8000 modular analyzer (c701 module, Roche, Mannheim)
subsequent a color test method (Bromocresol green) with
endpoint measure.
Data analysis
Magnetic resonance image analysis was performed blindly by a
radiologist in training (TR) and a research assistant with 1 year of
training in analyzing abdominal MR image data (CB). Purpose
built software tools implemented in MATLAB (The MathWorks,
Natick, MA, USA) and IDL (Exelis Visual Information Solutions)
were applied for extraction of gastric content volume, gastric
secretion, gallbladder volume, and intestinal fluid content.
Gastric content contours were segmented in each transverse
image by a semi-automated algorithm. Respective 3D gastric
content volumes were computed from 3D isosurfaces of the
contours.13 Gallbladder contours and small intestinal areas
excluding blood vessels and visceral tissues were manually
contoured in each T2-weighted coronal image slice. To assess
intestinal fluid content, a signal threshold was selected to
segment the bright luminal fluid content from air and surround-
ing soft tissue. Intestinal fluid volume was calculated by
summing all segmented pixels. Gastric secretion volume was
analyzed from reconstructed T1 maps according to a previously
established analysis method.13
Figure 1 Schematic of the human study
protocol. The schematic depicts the
sequence of MRI measurements, venous
blood sampling, and visceral sensation
ratings as performed in all three study
sessions.
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Magnetic resonance parameters were smoothed using function
loess (with smoothing parameter a = 1) in program R 16 and
plotted over time and LMH dose. Halftimes of gastric emptying
(t50) were calculated from smoothed curves by solving the locally
smoothed interpolation for 50% using the Newton method.17
Dose response of t50 was analyzed by linear mixed model with
t50 and LMH dose as fixed effects and subject as random effect.
Dose response of gallbladder and intestinal fluid volumes was
analyzed by linear mixed model with volume, time, and LMH
dose as fixed effects and subject as random effect.
The density functions of individual mean visceral sensations
scores were plotted. As the resulting distributions were domi-
nated by zero values, visceral sensations scores were divided into
two categories, i.e., 0 and ≥1, to only test for a dose-dependent
increase in scores not zero. The dose-dependent effect of L-lysine
on the binomial visceral sensations scores was analyzed using
generalized linear models with a binominal link function.
Deltas over baseline (DOB) values were calculated for L-lysine
and albumin concentrations, all blood gas parameters, and base
excess. Baseline was defined as the values detected at fasted state.
DOB values were smoothed using function loess and plotted over
time and LMH dose. Dose response was analyzed by linear mixed
models with DOB of blood gas parameters, time, and LMH dose as
fixed effects and subject as random effect. Estimated model
parameters are presented as estimate  standard error. A signif-
icance level of 0.05 was chosen.
RESULTS
Animal experiments
To identify a dose-dependent impact of L-lysine on rat
GI function, we administered different isomolar doses
of L-lysine intragastrically and measured GI tract wet
weight and phenol red transit 30 min post-application.
The doses applied ranged from 0 to 800 mg L-lysine per
animal covering the span of daily L-lysine intake in
rats.12 Rat stomach and cecum wet weight dose
dependently increased by 0.4  0.04 g/0.1 g L-lysine
(p < 0.0001) and 0.2  0.01 g/0.1 g L-lysine (p = 0.03),
respectively (Fig. 2A and B). No other GI segments
showed a dose-dependent change in wet weight. As
animals did not have access to water or food, we
interpreted these wet weights changes to reflect alter-
ations in secretion or absorption, respectively. To
assess GI motility more specifically, we tracked the
transit of a dye (phenol red) along the GI segments
30 min postapplication. By measuring residual phenol
red in the stomach, we observed delayed gastric
emptying by increased gastric phenol red content of
3.0  0.8% per 0.1 g L-lysine (p < 0.001) and decreased
small intestinal phenol red content of also 3.0  0.4%
per 0.1 g L-lysine (p < 0.0001, Fig. 3A and B). In
accordance, colon phenol red content decreased by
0.3  0.08% per 0.1 g L-lysine (p < 0.001, Fig. 3C). The
gastric and intestinal phenol red content appeared to
plateau at the two higher L-lysine doses. These data
show that L-lysine dose dependently delayed gastric
emptying and stimulated gastric secretion in rats. In
addition, cecum wet weight increased dose depen-
dently indicating alterations in intestinal, pancreatic,
or biliary secretion. This data is limited to the 30 min
time point, thereby potentially obscuring lower dose
effects of L-lysine.
Human experiments
To assess the translational aspects of L-lysine impact
on GI function, we conducted a MRI based study in
healthy human subjects. Briefly, we administered
different isomolar doses of L-lysine nasogastrically
and measured the impact on GI function and blood
gas parameters every 15 min over a time course of
90 min. The administered doses were between 0.5 and
7.5 g L-lysine per test meal, which is considered
physiological relevant as the daily L-lysine intake
varies between 2 and 9 g/day.14 In one subject, L-lysine
measurements for one dose had to be dismissed due to
non-compliance with study procedure (subject P4, 3 g
L-lysine dose). After L-lysine application, blood
L-lysine concentration increased dose dependently
A B
Figure 2 Dose-dependent effect of
intragastric L-lysine administration on GI
wet weight in rats. L-lysine dose
dependently increased stomach (A) and
cecum wet weight (B) in rats. Individual
points represent wet weight measurements
of individual animals treated with the
respective L-lysine dose. The predicted
linear dose–response curve is presented as
solid line. L-lysine doses (x-axis) are plotted
in log2.0 scale.
© 2014 John Wiley & Sons Ltd 1003
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over time by 0.54  0.1 lM/min/g L-lysine
(p < 0.0001, Fig. 4A and B) demonstrating proper appli-
cation and absorption. No dose-dependent differences
were found for albumin or any of the blood parameters.
At the level of the stomach, L-lysine dose dependently
delayed gastric emptying by an increase in t50 of
4.2  1.4 min/g L-lysine (p = 0.01, Fig. 5A and B).
The infused test meals with 0.5 g and 1.2 g L-lysine
emptied similar to a drink of 300 mL of water.18 No
changes in gallbladder volume or gastric secretion were
detected based on MRI. In the small intestine, L-lysine
dose- and time-dependently increased fluid volume by
0.37  0.1 mL/min/g L-lysine (p < 0.0001, Fig. 6A and
B). This effect and its dynamics were clearly detectable
in the MR image data (Fig. 7). During the 100 min
postprandial period, no side effects or dose-dependent
changes in self-reported visceral sensations were
found. After end of study protocol, defecation was
altered after the intake of 7.5 g L-lysine, as four of five
subjects receiving this highest dose retrospectively
reported self-limiting diarrhea within 1–6 h after
L-lysine application. No such change in defecation
was reported for any other dose. In summary, these
findings confirm the dose-dependent delay in gastric
A B
Figure 4 Dose-dependent L-lysine concentrations in venous blood after intragastric application of L-lysine in humans. Data are expressed as
delta over baseline (DOB) with baseline values measured before intragastric L-lysine infusion. (A) Smoothed DOB L-lysine concentration curves
(lines) overlaid on the individual measurements (points) of all human subjects, each treated with three (of the total four) different L-lysine doses.
L-lysine concentration data of one dose in subject P4 were dismissed due to non-compliance of study protocol. (B) The average linearly predicted
L-lysine concentration increase per dose.
A B C
Figure 3 Dose-dependent effect of intragastric L-lysine administration on phenol red content in rats. Phenol red content is expressed as percentage
of the initially administered total phenol red amount. L-lysine dose dependently increased gastric phenol red content (A) and decreased small
intestinal (B) and colon (C) phenol red content in rats. Individual points represent residual phenol red content measurements of individual animals
treated with the respective L-lysine dose. The predicted linear dose–response curve is presented as solid line. L-lysine doses (x-axis) are plotted in
log2.0 scale.
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emptying and demonstrate an increase in intestinal
liquid content in humans.
DISCUSSION
This study revealed several similar functional
responses of the GI tract to L-lysine stimulus in
humans and rats. In both species, gastric and small
intestinal functions were effectively altered after
intragastric infusion of L-lysine.
L-lysine delayed gastric emptying revealing a con-
served amino acid-specific effect in rats and humans.
This delay seemed not to trigger a temporal delay of
L-lysine absorption into the blood stream in humans
for enabling postgastric regulatory mechanisms. Gas-
tric emptying is generally accepted to be primarily
controlled by the volume and the caloric equivalent of
the gastric load.1 The two low-dose test meals (0.5 and
1.2 g) emptied faster or similar to a 300 mL drink of
water,18 while the highest 7.5 g L-lysine dose delayed
the volume emptying by ~30 min. The negligible
caloric differences between the lowest and highest
L-lysine doses in humans (<23 kcal) and also rats
(<5 kcal) suggest a caloric-independent mechanism for
the observed alterations in gastric emptying. This
amino acid-specific mechanism for the control of GI
A B
Figure 5 Dose-dependent effect of intragastric L-lysine application on gastric emptying in humans. (A) Smoothed gastric emptying curves (lines)
overlaid on the individual volume measurements (points) of all human subjects, each treated with three (of the total four) different L-lysine doses.
(B) L-lysine dose dependently increased t50 (computed from smoothed gastric emptying curves) in humans. The predicted linear increase is indicated
as solid line. Values of t50 (y-axis) are plotted in log10 scale, L-lysine doses (x-axis) are plotted in log2.5 scale.
A B
Figure 6 Dose-dependent effect of intragastric L-lysine application on intestinal fluid volume in humans. (A) Smoothed intestinal fluid volume
curves (lines) overlaid on the individual volume measurements (points) of all human subjects, each treated with three (of the total four) different
L-lysine doses. (B) The average linearly predicted intestinal fluid volume change per dose.
© 2014 John Wiley & Sons Ltd 1005
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function has been recently proposed for L-lysine,
L-arginine, and L-glutamic acid in rats12 and is here-
with confirmed for humans. Beyond that, the former
rat study showed that intravenous L-arginine and
L-lysine did not modulate GI function indicating a
potential GI luminal mechanism of action.12
This work’s focus was limited to the short-term
effect of L-lysine on GI motor function in rats and
humans. Our previous work in rats did not suggest a
long-term effect, as L-lysine reduced food intake only
in the first hour after application, but did not alter
energy intake in the subsequent hours.19 On the basis
of this anorectic effect, we concluded that L-lysine acts
in the short term rather than in the long term. No
simultaneous measurements of enteroendocrine hor-
mones were performed that would have allowed to gain
further insights with regard to the mechanism or site of
action. Indeed, L-lysine might have stimulated the
release of specific GI hormones. For instance, the
release of the gut hormone GLP-1 from primary murine
intestinal cells was shown to be induced by L-glutamic
acids.20 Similar L-phenylalanine and L-tryptophan
were reported to stimulate cholecystokinin (CCK)
secretion from primary cells.21 These findings demon-
strated the remarkable amino acid specificity for the
secretory function of endocrine cells ex vivo. However,
the specific impact of L-lysine on GI hormone release
and their relevance for the modulation of GI function
in vivo are currently unknown. The underlying
regulatory mechanism of the L-lysine effect might
have also involved vagal signaling. Several ex vivo
electrophysiological studies revealed amino acid spec-
ificity of vagal firing as different amino acids excite or
inhibit vagal afferent activity dependent on the
exposed vagal branch.4–8 Interestingly, of all amino
acids tested, only intragastric L-glutamic acid induced
vagal signaling ex vivo indicating the necessity for
amino acid absorption.22,23 Hepatic vagal afferents fire
specifically to an L-lysine stimulus and they were
shown to mediate the anorectic effect of L-lysine in
rats.8,12 Taken together, this study showed that
L-lysine dose dependently delayed gastric emptying
suggesting a caloric-independent mechanism for the
control of GI function also in humans.
Gastric secretion was dose dependently induced in
animals, but not in humans. Importantly, delayed
Figure 7 MR image data highlighting the dose-dependent effect of intragastric L-lysine application on gastrointestinal fluid volume in humans. The
difference in the accumulation of intestinal fluid volume and the delay in gastric emptying between L-lysine doses 1.2 and 7.5 g is depicted over
60 min in representative MR image data of one subject (P6). Imaged GI organs and anatomical landmarks are indicated.
© 2014 John Wiley & Sons Ltd1006
C. Baruffol et al. Neurogastroenterology and Motility
gastric emptying and secretion had a different dose–
response curve in rats. Hence, the L-lysine doses used
here in humans might have been insufficient to exten-
sively stimulate gastric secretion. A formerly more
invasive study by Sackler et al. applying repeated
extraction of gastric content with subsequent titration
reported increased gastric pepsin andHCl secretion after
application of 5-g L-lysine combined with a solid test
meal.24 Hence, the test meal composition and the
sampling method might have synergized with L-lysine
to induce increased gastric secretion. It is understood
that gastric secretion is mainly mediated by parietal
cells. Here, we did not assess if L-lysine stimulated
parietal secretion directly or induced histamine secre-
tion by enterochromaffin cells; however, because hista-
mine not only induces gastric secretion but also delays
gastric emptying this might be an alternativemediatory
mechanism of the observed L-lysine action.25,26 The
lack of L-lysine’s effect on gastric secretion in humans
was reflected and supported by the absence of any
differences in blood gas parameters and base excess.
Gastric secretion was previously shown to correlate
with base excess in blood, an effect termed alkaline
tide.27 Taken together, L-lysine induced gastric secre-
tion at high doses in rats, and a similar effect might be
probable in humans. However, its analysis is hampered
by the diarrhea inducing side effect of L-lysine doses
≥7 g. The reported side effects of self-limiting diarrhea
for the highest L-lysine dose of 7.5 g in humans were
accompanied by an increase in intestinal fluid volume.
In both humans and rats, a dose-dependent increase in
intestinal fluid volume, respectively cecumwetweight,
was observed. The origin of this fluid accumulation
remains currently unclear, but might arise either from
increased bile and pancreatic secretions, reduced lumi-
nal absorption, and/or active intestinal fluid influx.
A simple osmotic effect seems unlikely, because we
applied isomolar L-lysine solutions. As no dose-depen-
dent effect on gallbladder volume was detected in
humans, and because rats have no gallbladder, the latter
two possibilities are currently the more likely reasons
for this phenomenon.
In healthy humans, the apparent impact of L-lysine
on gastric and small intestinal function did not
translate into changes in visceral sensations scores.
Hunger and fullness were the only scores to exhibit
density functions with modes different from zero.
Therefore, a simplified ordinal, i.e. binomial, model
analysis had to be applied to test for a dose-dependent
increase in scores ≥1. This finding might not be
surprising given the low numbers of study participants
and the multitude of determinants of visceral sensi-
tivity.28 A larger number of volunteers would be
needed to conclude on the effect of L-lysine on human
satiation.
The here presented work focused on liquid emptying.
This may be regarded as methodological simplification
in so far as animals and humans normally ingest solid
and semi-solid meals, respectively. However, it is
important to acknowledge that after a so-called ‘lag
phase’, solid meals empty at a similar rate as liquid
meals of similar composition and energy content.29
Within this initial phase of gastric emptying, secretion
and motor activity process the ingested food into a
liquid-like dispersion that can pass through the pyloric
opening. Hence, the focus on liquid emptying is also
reasonable from a physiological perspective.30,31 This is
also supported by previous data in rats showing delayed
solid gastric emptying at a L-lysine dose of 6.7 mmol/
kg.19Within the human setting, liquid gastric emptying
has become of more interest also in the clinical setting
and is currently evaluated as a method for the detection
of gastroparesis.32–35 In conclusion, this translational
study demonstrates comparable dose-dependent effects
of intragastric L-lysine on GI function in humans and
rats, in particular stomach and small intestinal func-
tion. This conserved chemospecificity supports a
broader role for individual amino acids in the control
of GI transport and secretion in vivo.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Figure S1. Albumin concentration and blood gas parameters from venous blood after intragastric L-lysine
application in humans.
Figure S2. Visceral sensations scores after intragastric L-lysine application in humans.
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